Edition:
United Kingdom

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

0.51USD
5:42pm BST
Change (% chg)

$0.02 (+4.37%)
Prev Close
$0.49
Open
$0.50
Day's High
$0.54
Day's Low
$0.48
Volume
191,755
Avg. Vol
157,392
52-wk High
$2.42
52-wk Low
$0.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.07 -0.241
Jun '17 0.15 -0.276
Mar '17 0.18 -0.279
FY 2016 Dec '16 0.16 -0.376
Sep '16 0.27 -0.364
Jun '16 0.23 -0.457
Mar '16 0.00 -0.311
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.19 -0.19 -0.19 -0.24
Quarter Ending Sep-18 1 -0.14 -0.14 -0.14 -0.23
Year Ending Dec-18 1 -0.65 -0.65 -0.65 0.95
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.74
P/E High - Last 5 Yrs. -- 40.70 45.72
P/E Low - Last 5 Yrs. -- 23.63 24.22
Beta -- 0.89 0.88
Price to Sales (TTM) 27.35 3.94 5.71
Price to Book (MRQ) 4.59 4.80 5.37
Price to Tangible Book (MRQ) -- 5.61 6.95
Price to Cash Flow (TTM) -- 22.91 23.32
% Owned Institutions 39.45 1.21 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -36.79 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago 227.14 4.83 5.69
Sales - 5 Yr. Growth Rate -- 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.61 16.36 19.36
EPS (TTM) vs TTM 1 Yr. Ago 0.93 -- --
EPS - 5 Yr. Growth Rate -- 9.87 10.76
Capital Spending - 5 Yr. Growth Rate -- 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 1.13 2.90 2.98
LT Debt to Equity (MRQ) 0.21 9.88 12.18
Total Debt to Equity (MRQ) 0.21 13.86 16.45
Interest Coverage (TTM) -963.38 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.44
Gross Margin - 5 Yr. Avg. -- 52.15 52.20
EBITD Margin (TTM) -1,734.30 -- --
EBITD - 5 Yr. Avg -- 18.57 10.96
Operating Margin (TTM) -1,736.12 14.36 4.73
Operating Margin - 5 Yr. Avg. -- 14.52 6.40
Pre-Tax Margin (TTM) -1,736.10 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.90 6.81
Net Profit Margin (TTM) -1,736.10 11.08 1.87
Net Profit Margin - 5 Yr. Avg. -- 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 938,079,949 846,830,978
Net Income/Employee (TTM) -- 110,368,367 99,616,195
Receivable Turnover (TTM) 6.48 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) 0.05 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.70 11.40 10.95
Return on Assets - 5 Yr. Avg. -- 12.91 12.31
Return on Investment (TTM) -193.34 14.84 14.38
Return on Investment - 5 Yr. Avg. -- 16.88 16.10
Return on Equity (TTM) -241.44 16.34 16.07
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for EyeGate Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.72%
# of Holders: 23
Total Shares Held: 5,600,076
3 Mo. Net Change: -259,437
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.